Telisotuzumab (Synonyms: ABT-700) |
| Catalog No.GC70006 |
Telisotuzumab (ABT-700) est un anticorps thérapeutique bivalent recombinant humanisé ciblant le récepteur du facteur de croissance des hépatocytes (MET), capable de se lier avec une haute affinité à c-Met et d'inhiber la signalisation de c-Met. Telisotuzumab possède une activité anti-tumorale.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1781223-80-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Telisotuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Telisotuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *